Up | AC
Home Page
Food and
Drug Administration
Pediatric
Subcommittee of the Oncologic Drugs Advisory Committee
June 27, 2007
BREIFING
INFORMATION
FDA
Disclaimer
Portions of
this document have been determined to be exempt from disclosure under the
Freedom of Information Act (the FOIA) (5 U.S.C. § 552). These redacted portions
will appear as white space on the screen or on the printed page.
FDA
Briefing Material (pdf)
Bibliography
(pdf)